Peter William Blumencranz MD FACS
Breast, Melanoma, Surgical Oncology (Other than Breast)
Medical Director, BayCare Cancer Institute
Join to View Full Profile
400 Pinellas StSuite 200Clearwater, FL 33756
Phone+1 727-462-2131
Fax+1 727-266-4914
Dr. Blumencranz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1976 - 1977
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1974 - 1976- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1970 - 1972
Weill Cornell MedicineClass of 1970
Certifications & Licensure
NY State Medical License Current
FL State Medical License 1976 - 2027
VA State Medical License 1972 - 2000
Awards, Honors, & Recognition
- Fellow Society of Surgical Oncology
- Fellow Southeastern Surgical Congress
- CMS Meaningful Use Stage 1 Certification Powerchart (Image Results), Cerner Corporation, 2016
Clinical Trials
- Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2007 Jul 01
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- ASO Visual Abstract: The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to have Nodal D...Peter Blumencranz, Mehran Habibi, Steve Shivers, Geza Acs, Lisa E Blumencranz
Annals of Surgical Oncology. 2024-01-01 - 9 citationsThe Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Path...Peter Blumencranz, Mehran Habibi, Steve Shivers, Geza Acs, Lisa E Blumencranz
Annals of Surgical Oncology. 2023-12-01 - 28 citationsIntraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery.Barbara L Smith, Kelly K Hunt, David Carr, Peter W Blumencranz, E Shelley Hwang
NEJM Evidence. 2023-07-01
Press Mentions
Hype or Hope? 14 Oncology Leaders Weigh in on GLP-1sMarch 2nd, 2026- BayCare Launches High Risk Cancer ProgramOctober 29th, 2025
- BayCare Launches Free Cancer Risk Survey to Catch High-Risk Cases EarlyOctober 6th, 2025
Professional Memberships
- Member
- Member
- Board of Directors
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
